Display Settings:

Format

Send to:

Choose Destination

    Arch Biochem Biophys. 2007 Jan 1;457(1):29-34. Epub 2006 Nov 10.

    Lithium ions increase hepatic glycogen synthase stability through a proteasome-related mechanism.

    Fernández-Novell JM, Rodríguez-Gil JE, Barberà A, Guinovart JJ.

    Departament de Bioquímica i Biologia Molecular, Universitat de Barcelona, Avgda. Diagonal 645, Edifici nou planta-1, E-08028 Barcelona, Spain. jmfernandeznovell@ub.edu

    Incubation of rat hepatocytes with LiCl resulted in an overall increase in the activity ratio of glycogen synthase (GS), concomitantly with a decrease in active GS kinase-3 levels. GS total activity was also increased in a dose- and time-dependent manner. This latter effect correlated with the amount of immunoreactive enzyme determined by immunoblotting. Cycloheximide and actinomycin-D did not modify LiCl action on GS activity. Lithium ions did not induce any changes in GS mRNA levels. Furthermore, the increase in the total amount of GS induced by LiCl was further augmented after addition of a specific, calpain and proteasome inhibitor. Our results indicate that LiCl increases hepatocyte GS activity through increasing both the activation state of the enzyme and its cellular content. This latter increase is mediated through a modification of the proteasome-regulated proteolytic pathway of the enzyme.

    PMID: 17125726 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Lithium (Eskalith CR®, Eskalith®, Lithobid®)

      Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and ...

    • Dactinomycin (Cosmegen®)

      Your doctor has ordered the drug dactinomycin to help treat your illness. The drug is given by injection into a vein.